Replies to post #34560 on RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

K-G, That's shown as a preclinical program targeting AD (link below). Servier still owns a few compounds that came out of the former collaboration with Cortex. Servier had the Euro rights to neurodegenerative indications, but that partnership was ended early by Cortex -

http://www.cortexpharm.com/prodpipe/index.html